Related Experiment Videos
Summary
Hematoporphyrin derivative (HpD) photodynamic therapy shows promise for bladder cancer. This treatment aids tumor localization and effectively destroys transitional cell carcinoma, though recurrence rates require further study.
Area of Science:
- Oncology
- Photodynamic Therapy
- Urologic Oncology
Background:
- Transitional cell carcinoma of the bladder lacks effective tumor-localization aids.
- Hematoporphyrin derivative (HpD) exhibits cytotoxic effects upon light activation.
Purpose of the Study:
- To evaluate HpD photodynamic therapy (PDT) as a tumor-localization aid and treatment for bladder cancer.
- To assess efficacy in both focal and diffuse bladder cancer types.
Main Methods:
- Utilized an argon-ion, pumped-dye laser for red light delivery.
- Administered HpD PDT to patients with focal and diffuse bladder cancer.
- Evaluated treatment outcomes via cystoscopic examination.
Main Results:
- Focal disease treatment showed initial lesion disappearance, but high recurrence rates were observed.
- Whole-bladder HpD PDT in diffuse carcinoma in situ demonstrated effectiveness.
- Adverse effects included cutaneous photosensitivity and bladder irritability.
Conclusions:
- HpD serves as a valuable tumor-localizing agent for transitional cell carcinoma of the bladder.
- HpD photodynamic therapy is an effective modality for destroying transitional cell carcinoma in the bladder.